🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if, once a favorable dose of TI I...
Status
Terminated
Location
Sansum Medical Research Institute
Start Date
2008-09
Trial ID
NCT00747006
Treatments Being Tested
Examine the effects of TI in combination with an anti-diabetic regimen incl...
Status
Terminated
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00642616
Treatments Being Tested
MKC-TI-191 is a Phase 4, single-arm, multicenter, proof-of-concept clinical...
Status
Completed
Location
AMCR Institute
Start Date
2021-04-09
Trial ID
NCT04849845
Treatments Being Tested
This study will investigate the effects of inhaled albuterol \& fluticasone...
Status
Completed
Location
ICON Development Solutions
Start Date
2008-05
Trial ID
NCT00674050
Treatments Being Tested
Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitu...
Status
Completed
Location
Profil Institute for Clinical Research
Start Date
2004-08
Trial ID
NCT00934414
Treatments Being Tested
INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2021-09-29
Trial ID
NCT04974528
Treatments Being Tested
A Phase 1, open-label randomized crossover trial in Healthy Volunteers to e...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01982604
Treatments Being Tested
Phase 1 clinical trial to evaluate insulin exposure using different formula...
Status
Completed
Location
Celerion
Start Date
2011-01
Trial ID
NCT01365117
Treatments Being Tested
The purpose of this study is to allow patients with specific needs for inha...
Status
No Longer Available
Location
Endocrinology Associates
Start Date
2008-10
Trial ID
NCT01798914
Treatments Being Tested
INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly...
Status
Completed
Location
Loma Linda University-Diabetes Treatment Center
Start Date
2023-07-07
Trial ID
NCT05904743
Treatments Being Tested